Clinical Trials Logo

Melanoma With Brain Metastasis clinical trials

View clinical trials related to Melanoma With Brain Metastasis.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03903640 Terminated - Clinical trials for Melanoma With Brain Metastasis

Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis

Start date: October 14, 2019
Phase: Phase 2
Study type: Interventional

This phase II study will evaluate the safety of combining intermediate frequency electric field (TT Field) with immunotherapy in melanoma patients with brain metastasis. The data of this study will also inform whether this combination will offer advantage in progression free survival (PFS) and overall survival.